Literature DB >> 28933425

Carnosine suppresses oxygen-glucose deprivation/recovery-induced proliferation and migration of reactive astrocytes of rats in vitro.

Li Ou-Yang1, Yuan Liu1, Bing-Yu Wang1, Pei Cao1, Jing-Jing Zhang1, Yu-Yan Huang1, Yao Shen1, Jian-Xin Lyu1,2.   

Abstract

Glial scar formation resulted from excessive astrogliosis limits axonal regeneration and impairs recovery of function, thus an intervention to ameliorate excessive astrogliosis is crucial for the recovery of neurological function after cerebral ischemia. In this study we investigated the effects of carnosine, an endogenous water-soluble dipeptide (β-alanyl-L-histidine), on astrogliosis of cells exposed to oxygen-glucose deprivation/recovery (OGD/R) in vitro. Primary cultured rat astrocytes exhibited a significant increase in proliferation at 24 h recovery after OGD for 2 h. Pretreatment with carnosine (5 mmol/L) caused G1 arrest of reactive astrocytes, significantly attenuated OGD/R-induced increase in cyclin D1 protein expression and suppressed OGD/R-induced proliferation of reactive astrocytes. Carnosine treatment also reversed glycolysis and ATP production, which was elevated at 24 h recovery after OGD. A marked increase in migration of reactive astrocytes was observed at 24 h after OGD, whereas carnosine treatment reversed the expression levels of MMP-9 and suppressed the migration of astrocytes. Furthermore, carnosine also improved neurite growth of cortical neurons co-cultured with astrocytes under ischemic conditions. These results demonstrate that carnosine may be a promising candidate for inhibiting astrogliosis and promoting neurological function recovery after ischemic stroke.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28933425      PMCID: PMC5758661          DOI: 10.1038/aps.2017.126

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  36 in total

Review 1.  Regeneration beyond the glial scar.

Authors:  Jerry Silver; Jared H Miller
Journal:  Nat Rev Neurosci       Date:  2004-02       Impact factor: 34.870

Review 2.  Energy metabolism, proteotoxic stress and age-related dysfunction - protection by carnosine.

Authors:  Alan R Hipkiss
Journal:  Mol Aspects Med       Date:  2011-10-15

Review 3.  Inhibition of tumour cell growth by carnosine: some possible mechanisms.

Authors:  Alan R Hipkiss; Frank Gaunitz
Journal:  Amino Acids       Date:  2013-12-01       Impact factor: 3.520

4.  Carnosine attenuates mast cell degranulation and histamine release induced by oxygen-glucose deprivation.

Authors:  Yao Shen; Shihong Zhang; Lin Fu; Weiwei Hu; Zhong Chen
Journal:  Cell Biochem Funct       Date:  2008-04       Impact factor: 3.685

5.  Carnosine is neuroprotective against permanent focal cerebral ischemia in mice.

Authors:  G K Rajanikant; Daniel Zemke; Marie-Claude Senut; Mark B Frenkel; Alex F Chen; Rishi Gupta; Arshad Majid
Journal:  Stroke       Date:  2007-10-04       Impact factor: 7.914

6.  Carnosine attenuates oxidative stress and apoptosis in transient cerebral ischemia in rats.

Authors:  C Pekcetin; Muge Kiray; B U Ergur; K Tugyan; H A Bagriyanik; G Erbil; Basak Baykara; U M Camsari
Journal:  Acta Biol Hung       Date:  2009-06

7.  Oxygen-glucose deprivation induced glial scar-like change in astrocytes.

Authors:  Rongrong Wang; Xiangnan Zhang; Jianxiang Zhang; Yanying Fan; Yao Shen; Weiwei Hu; Zhong Chen
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

8.  Carnosine inhibits the proliferation of human gastric cancer SGC-7901 cells through both of the mitochondrial respiration and glycolysis pathways.

Authors:  Yao Shen; Jianbo Yang; Juan Li; Xiaojie Shi; Li Ouyang; Yueyang Tian; Jianxin Lu
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

9.  L-carnosine affects the growth of Saccharomyces cerevisiae in a metabolism-dependent manner.

Authors:  Stephanie P Cartwright; Roslyn M Bill; Alan R Hipkiss
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

10.  Carnosine: can understanding its actions on energy metabolism and protein homeostasis inform its therapeutic potential?

Authors:  Alan R Hipkiss; Stephanie P Cartwright; Clare Bromley; Stephane R Gross; Roslyn M Bill
Journal:  Chem Cent J       Date:  2013-02-25       Impact factor: 4.215

View more
  9 in total

1.  AMPK Modulates the Metabolic Adaptation of C6 Glioma Cells in Glucose-Deprived Conditions without Affecting Glutamate Transport.

Authors:  Inês Belo do Nascimento; Marie Verfaillie; Gamze Ates; Pauline Beckers; Virginie Joris; Nathalie Desmet; Ann Massie; Emmanuel Hermans
Journal:  Cells       Date:  2022-05-31       Impact factor: 7.666

Review 2.  Antioxidant and Neuroprotective Effects of Carnosine: Therapeutic Implications in Neurodegenerative Diseases.

Authors:  Cristina Solana-Manrique; Francisco José Sanz; Guillermo Martínez-Carrión; Nuria Paricio
Journal:  Antioxidants (Basel)       Date:  2022-04-26

3.  Carnosine selectively inhibits migration of IDH-wildtype glioblastoma cells in a co-culture model with fibroblasts.

Authors:  Henry Oppermann; Johannes Dietterle; Katharina Purcz; Markus Morawski; Christian Eisenlöffel; Wolf Müller; Jürgen Meixensberger; Frank Gaunitz
Journal:  Cancer Cell Int       Date:  2018-08-13       Impact factor: 5.722

Review 4.  The Role of Mast Cells in Stroke.

Authors:  Edoardo Parrella; Vanessa Porrini; Marina Benarese; Marina Pizzi
Journal:  Cells       Date:  2019-05-10       Impact factor: 6.600

5.  TRPV1 translocated to astrocytic membrane to promote migration and inflammatory infiltration thus promotes epilepsy after hypoxic ischemia in immature brain.

Authors:  Xin Wang; Xing-Liang Yang; Wei-Lin Kong; Meng-Liu Zeng; Lin Shao; Guang-Tong Jiang; Jing-Jing Cheng; Shuo Kong; Xiao-Hua He; Wan-Hong Liu; Tao-Xiang Chen; Bi-Wen Peng
Journal:  J Neuroinflammation       Date:  2019-11-13       Impact factor: 8.322

6.  The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke.

Authors:  Yilong Shan; Sha Tan; Yinyao Lin; Siyuan Liao; Bingjun Zhang; Xiaodong Chen; Jihui Wang; Zhezhi Deng; Qin Zeng; Lei Zhang; Yuge Wang; Xueqiang Hu; Wei Qiu; Lisheng Peng; Zhengqi Lu
Journal:  J Neuroinflammation       Date:  2019-11-28       Impact factor: 8.322

7.  Sigma 1 Receptor Modulates Optic Nerve Head Astrocyte Reactivity.

Authors:  Jing Zhao; Graydon Gonsalvez; Manuela Bartoli; Barbara A Mysona; Sylvia B Smith; Kathryn E Bollinger
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-06-01       Impact factor: 4.799

8.  A Novel 5-Chloro-N-phenyl-1H-indole-2-carboxamide Derivative as Brain-Type Glycogen Phosphorylase Inhibitor: Potential Therapeutic Effect on Cerebral Ischemia.

Authors:  Yatao Huang; Shuai Li; Youde Wang; Zhiwei Yan; Yachun Guo; Liying Zhang
Journal:  Molecules       Date:  2022-09-26       Impact factor: 4.927

9.  Cinnamaldehyde protects against rat intestinal ischemia/reperfusion injuries by synergistic inhibition of NF-κB and p53.

Authors:  Marwan Almoiliqy; Jin Wen; Eskandar Qaed; Bin Xu; Yu-Chao Sun; Meng-Qiao Lian; Yan-Li Li; Mahmoud Al-Azab; Da-Peng Chen; Abdullah Shopit; Li Wang; Peng-Yuan Sun; Yuan Lin
Journal:  Acta Pharmacol Sin       Date:  2020-04-01       Impact factor: 6.150

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.